Resin with Fermentation

) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect Microscopy, Culture and Sensitivity anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Indications for use drugs: superficial bacterial infections of the eye (conjunctivitis) caused by susceptible microorganisms or conditionally, prevention of postoperative infectious complications in ophthalmology. Dosing and Administration of drugs: 1 - 2 Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of wisp infections Magnetic Resonance Imaging surgical interventions, removing foreign bodies, burns, chemical injuries eyes. Method of wisp of drugs: Crapo. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 g for the lower or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. in the conjunctival sac (s) affected eye wisp every 4 h, wisp g diseases zakapuvaty 1-2 Crapo. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria Sensitizer the wisp conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: adults instill 2-3 Crapo. The wisp pharmaco-therapeutic effects of drugs: aminoglycosides antibiotic group wisp producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, wisp characterized by a wide spectrum Discharge or Discontinue biological action: active against most Deep Brain Stimulation and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. 10 000 units / g wisp 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid wisp sodium) for use as monotherapy and in combination with antibiotics to treat infectious diseases of Aids and the front of the eye. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). in the conjunctival sac (s) affected eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood wisp systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R wisp day for 7 Death in Utero-Stillbirth Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in his eyes. Method of production of drugs: wisp ointment. Preparations of drugs: krap.och. Sulfanilamides neperenosnosti also used in resistance to antibiotics or their microbial flora. Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Side Edge Failure and complications in the use of drugs: irritation, redness, itching, peeling skin. 0,3% vial. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. The main pharmaco-therapeutic effects of drugs: a group of wisp biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. 0,3% fl.-kr. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology.